Doi Yuko, Tamano Seiko, Kawabe Mayumi, Sano Masashi, Imai Norio, Nakashima Hironao, Furukawa Fumio, Hagiwara Akihiro, Otsuka Masanori, Shirai Tomoyuki
J Toxicol Pathol. 2011 Dec;24(4):207-13. doi: 10.1293/tox.24.207. Epub 2012 Jan 7.
This study was conducted to determine the concordance of results for a pair of structural isomers, 2-nitropropane (2-NP) and 1-nitropropane (1-NP), using the rat medium-term liver carcinogenesis bioassay (Ito test) and previously published long-term carcinogenicity tests. Male F344 rats were given a single intraperitoneal injection of DEN (200 mg/kg b.w.) to initiate hepatocarcinogenesis. After 2 weeks, they received per os 0, 0.8, 4 or 20 mg/kg/day of 2-NP or 1-NP six times a week and were subjected to two-thirds partial hepatectomy at week 3. Non-initiated groups receiving 0 or 20 mg/kg/day were also included. The animals were sacrificed for quantitative analysis of GST-P-positive foci at week 8. With the highest dose of 2-NP, significantly increased numbers and areas of GST-P-positive foci were demonstrated as compared with the respective control but were not noted with 1-NP. In the non-DEN-initiated groups, many small GST-P-positive foci of less than 0.2 mm in diameter were also induced in the rats treated with 2-NP at 20 mg/kg/day but were lacking with 1-NP. These results strongly support that 2-NP is a complete hepatocarcinogen with a potent initiation activity, whereas 1-NP is not.
本研究旨在通过大鼠中期肝脏致癌生物测定法(伊藤试验)和先前发表的长期致癌性试验,确定一对结构异构体2-硝基丙烷(2-NP)和1-硝基丙烷(1-NP)的结果一致性。雄性F344大鼠单次腹腔注射二乙基亚硝胺(DEN,200 mg/kg体重)以启动肝癌发生。2周后,它们每周6次经口给予0、0.8、4或20 mg/kg/天的2-NP或1-NP,并在第3周进行三分之二部分肝切除术。还纳入了接受0或20 mg/kg/天的未启动组。在第8周处死动物以对谷胱甘肽S-转移酶P(GST-P)阳性灶进行定量分析。与各自的对照组相比,2-NP最高剂量组的GST-P阳性灶数量和面积显著增加,但1-NP组未观察到这种情况。在未用DEN启动的组中,每天给予20 mg/kg 2-NP的大鼠也诱导出许多直径小于0.2 mm的小GST-P阳性灶,但1-NP组没有。这些结果有力地支持了2-NP是一种具有强大启动活性的完全致癌物,而1-NP则不是。